Announced Tue, 28 Jul · 10:38 IST
Newspaper publication of Q1 FY27 unaudited financial results
Compliance View source PDF
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
—1-day move
₹1397.90
prior close
₹1307.70
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.8+0.8+0.5——————————
Up moveDown movePending
AI summary
Senores Pharmaceuticals has published extracts of unaudited consolidated and standalone financial results for the quarter ended June 30, 2026 in Financial Express English and Gujarati editions on July 28, 2026. This is a routine regulatory compliance filing under SEBI listing rules. Specific financial figures are not included in this filing.
Likely market impact
Routine regulatory compliance filing. No direct impact on stock. Investors should refer to full quarterly results for financial details.